Please try another search
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.
Name | Age | Since | Title |
---|---|---|---|
Terry Sweet | 74 | 2014 | Independent Non-Executive Chairman |
Paul House | 51 | 2017 | Independent Non-Executive Director |
Richard John Lipscombe | - | 2001 | Co-Founder, MD & Director |
Ian Roger Moore | - | 2015 | Independent Non-Executive Director |
Robyn Elliott | 60 | 2021 | Independent Non-Executive Director |
Neville Gardiner | - | 2021 | Independent Non-Executive Chairman |
Eleuterio Ferrannini | - | 2022 | Member of Clinical Advisory Board |
Tim Davis | - | 2022 | Member of Clinical Advisory Board |
Merlin Thomas | - | 2022 | Member of Clinical Advisory Board |
Michael Shanik | - | 2022 | Member of Clinical Advisory Board |
Alexander Turchin | - | 2022 | Member of Clinical Advisory Board |
Neil Sholnik | - | - | Member of Clinical Advisory Board |
Hope Warshaw | - | - | Member of Clinical Advisory Board |
Davida F. Kruger | - | - | Member of Clinical Advisory Board |
Joshua Neumiller | - | - | Member of Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review